VICTOR PENA: Open Payments
NPI 1750812053 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$107 in 5 payments from 4 companies in 2025. Trend: 2023 $234 · 2024 $217 · 2025 $107
Food & beverage: $107
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $33 |
| Alkermes, Inc. | 2 | $31 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| ABBVIE INC. | 1 | $17 |
Products named: INGREZZA, ARISTADA, FANAPT, LINZESS.
Industry payments across TX — which companies pay providers there.
